Advertisement

Topics

Search Results for "BIAL Pharmaceuticals"

16:47 EDT 30th August 2016 | BioPortfolio

Matching Channels

Massachusetts

Located in the north-east corner of the USA, Massachusetts, has the third highest GDP of any state in America and is also a hotspot for the biotechnology industry. In addition to the globally renown...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Michigan

Surrounded by the Great Lakes in the north east of the US, Michigan hosts many high profile biotechnology companies and has become an industry hotbed. In 1993 MichBio was formed, as an industry tr...

Covidien

Covidien is the 9th largest global medical device company with annual sales in 2010 of almost $8 billion. Covidien was originally Tyco Healthcare, until June 2007, and has seen year-on-year growth s...

Matching News

EU clears Bial’s new Parkinson’s drug

The European Commission has approved Bial's Ongentys for Parkinson's disease patients with motor fluctuations.

European Commission approves Bial’s Ongentys

Bial said today that its Ongentys (opicapone) for the treatment of adult Parkinson´s disease patients…

Parkinson's treatment from Bial receives EU approval

Bial's Ongentys, or opicapone, has been approved by the European Commission as an adjunct treatment to preparations of levodo -More- 

Animal study indicated BIA 10-2474 was safe for human trials, says Bial

Preclinical data indicated BIA 10-2474 was safe to take into human trials according to Bial, which says dogs put down in toxicology studies had pulmonary lesions not injuries caused by the drug.

DIA: Calls for set standards in Phase I studies following Bial trial tragedy

Set standards for Phase I trials could stop serious adverse events and patient deaths, says a DIA panellist discussing the recent Bial trial tragedy.

UPDATE 2-France faults Bial and Biotrial over fatal drug trial

PARIS, May 23 (Reuters) - Portuguese drugmaker Bial and French laboratory Biotrial are at fault "on several counts" for a failed drug trial that left one person dead and five others hospitalised in Ja...

French Experts Ask Bial For More Preclinical Data On FAAH Inhibitor

The expert committee set up by the French medicines regulator ANSM to look into the preclinical data on Bial's FAAH inhibitor, BIA 10-2474, following the death of a volunteer and the hospitalization o...

Bial cannot rule out link between BIA 10-2474 and lung lesions in study dogs

Bial says it cannot be 100% certain BIA 10-2474 did not cause pulmonary lesions in dogs put down in toxicology study.

Matching PubMed Articles

Biotransformation of pharmaceuticals by ammonia oxidizing bacteria in wastewater treatment processes.

Pharmaceutical residues could potentially pose detrimental effects on aquatic ecosystems and human health, with wastewater treatment being one of the major pathways for pharmaceuticals to enter into t...

Removal of pharmaceuticals from secondary effluents by an electro-peroxone process.

This study compared the removal of pharmaceuticals from secondary effluents of wastewater treatment plants (WWTPs) by conventional ozonation and the electro-peroxone (E-peroxone) process, which involv...

Ranking Prescribed Pharmaceuticals in Terms of Environmental Risk: Inclusion of Hospital Data and the Importance of Regular Review.

A newly available dataset on pharmaceuticals used in Scottish hospitals enabled an Environmental Risk Assessment that includes hospital consumption of pharmaceuticals, as previous UK rankings have bee...

Announcing the 2016 Pharmaceuticals Travel Award for Young Investigators.

For the first time in its short history, our journal is able, this year, to support a young researcher in the field of medicinal chemistry by offering a travel grant of 800 CHF.[...].

Uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin and propranolol, in Daphnia magna.

The objective of the present study was to investigate the uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin (ROX) and propranolol (PRP), in Daphnia magna via aqueous expos...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement